Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Micrornas As Biomarkers for Early Diagnosis, Targeting and Prognosis of Prostate Cancer Publisher Pubmed



Azani A1, 2 ; Omran SP3 ; Ghasrsaz H4 ; Idani A3 ; Eliaderani MK5 ; Peirovi N6 ; Dokhani N7 ; Lotfalizadeh MH8 ; Rezaei MM9 ; Ghahfarokhi MS10 ; Karkonshayan S11 ; Hanjani PN12 ; Kardaan Z13 ; Navashenagh JG14 Show All Authors
Authors
  1. Azani A1, 2
  2. Omran SP3
  3. Ghasrsaz H4
  4. Idani A3
  5. Eliaderani MK5
  6. Peirovi N6
  7. Dokhani N7
  8. Lotfalizadeh MH8
  9. Rezaei MM9
  10. Ghahfarokhi MS10
  11. Karkonshayan S11
  12. Hanjani PN12
  13. Kardaan Z13
  14. Navashenagh JG14
  15. Yousefi M15
  16. Abdolahi M16
  17. Salmaninejad A1, 2, 17

Source: Pathology Research and Practice Published:2023


Abstract

Globally, prostate cancer (PC) is leading cause of cancer-related mortality in men worldwide. Despite significant advances in the treatment and management of this disease, the cure rates for PC remains low, largely due to late detection. PC detection is mostly reliant on prostate-specific antigen (PSA) and digital rectal examination (DRE); however, due to the low positive predictive value of current diagnostics, there is an urgent need to identify new accurate biomarkers. Recent studies support the biological role of microRNAs (miRNAs) in the initiation and progression of PC, as well as their potential as novel biomarkers for patients’ diagnosis, prognosis, and disease relapse. In the advanced stages, cancer-cell-derived small extracellular vesicles (SEVs) may constitute a significant part of circulating vesicles and cause detectable changes in the plasma vesicular miRNA profile. Recent computational model for the identification of miRNA biomarkers discussed. In addition, accumulating evidence indicates that miRNAs can be utilized to target PC cells. In this article, the current understanding of the role of microRNAs and exosomes in the pathogenesis and their significance in PC prognosis, early diagnosis, chemoresistance, and treatment are reviewed. © 2023 Elsevier GmbH
1. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
Experts (# of related papers)
Other Related Docs
4. Prostate Cancer and Noncoding Rnas: A Focus on Mirnas, Lncrnas, and Circrnas, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)
7. Reproducible and Reliable Real-Time Pcr Assay to Measure Mature Form of Mir-141, Applied Immunohistochemistry and Molecular Morphology (2016)
9. Microrna a New Gate in Cancer and Human Disease: A Review, Journal of Biological Sciences (2017)
12. Micrornas in Cancer, Synthesis Lectures on Biomedical Engineering (2022)